The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Src family kinases in tumor progression and metastasis
Abstract
The Src family of non-receptor protein tyrosine kinases plays critical roles in a variety of cellular signal transduction pathways, regulating such diverse processes as cell division, motility, adhesion, angiogenesis, and survival. Constitutively activated variants of Src family kinases, including the viral oncoproteins v-Src and v-Yes, are capable of inducing malignant transformation of a variety of cell types. Src family kinases, most notably although not exclusively c-Src, are frequently overexpressed and/or aberrantly activated in a variety of epithelial and non-epithelial cancers. Activation is very common in colorectal and breast cancers, and somewhat less frequent in melanomas, ovarian cancer, gastric cancer, head and neck cancers, pancreatic cancer, lung cancer, brain cancers, and blood cancers. Further, the extent of increased Src family activity often correlates with malignant potential and patient survival. Activation of Src family kinases in human cancers may occur through a variety of mechanisms and is frequently a critical event in tumor progression. Exactly how Src family kinases contribute to individual tumors remains to be defined completely, however they appear to be important for multiple aspects of tumor progression, including proliferation, disruption of cell/cell contacts, migration, invasiveness, resistance to apoptosis, and angiogenesis. This review details the evidence for Src family activation in human tumors, and emphasizes possible consequences to tumor progression. Given the ability of Src and its family members to participate in so many aspects of tumor progression and metastasis, Src family kinases are attractive targets for future anti-cancer therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SRC kinase, a cytoplasmic non-receptor tyrosine kinase, has been implicated in the development and progression of cancer [19–22].”
From Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer (2025) · cites this paper as [22]
In the citing paper
“In addition to MAPK, SRC kinases can directly modulate many downstream targets including and c-MYC [19, 21, 22, 44], related to drug resistance and tumor cell survival.”
From Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer (2025) · cites this paper as [22]
Citations
Cites
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
Thomas, S. Μ., & Brugge, J. S. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.513 · Cited by 2,537
Transforming gene product of Rous sarcoma virus phosphorylates tyrosine
Hunter, T. R., & Sefton, B. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1311 · Cited by 2,333
Three-dimensional structure of the tyrosine kinase c-Src
Xu, W., Harrison, S. C., & Eck, M. J. (1997) · Nature · doi:10.1038/385595a0 · Cited by 1,432
DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA
STEHELIN, D., VARMUS, H. E., BISHOP, J. M., & VOGT, P. K. (1976) · Nature · doi:10.1038/260170a0 · Cited by 1,321 · cited 2×
“Through then very tedious molecular approaches, Bishop and Varmus [3] demonstrated that the viral Src gene (v-src) had as its progenitor a normal cellular gene (proto-oncogene) c-src, an experiment largely responsible for the awarding of the”
BackgroundRegulation, substrates and functions of src
Brown, M. T., & Cooper, J. A. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00003-0 · Cited by 1,193
Crystal structure of the Src family tyrosine kinase Hck
Sicheri, F., Moarefi, I., & Kuriyan, J. (1997) · Nature · doi:10.1038/385602a0 · Cited by 1,171
A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS
Rous, P. (1911) · Journal of Experimental Medicine · doi:10.1084/jem.13.4.397 · Cited by 1,051
Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells.
Migliaccio, A., Domenico, M. D., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 950
Identification of a transformation-specific antigen induced by an avian sarcoma virus
Brugge, J. S., & Erikson, R. L. (1977) · Nature · doi:10.1038/269346a0 · Cited by 889
Role of Src expression and activation in human cancer
Irby, R., & Yeatman, T. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203912 · Cited by 878
Cited by
Items 101–200 of 845
Dasatinib: An Anti-Tumour Agent via Src Inhibition
Gnoni, A., Marech, I., Silvestris, N., Vacca, A., & Lorusso, V. (2011) · Current Drug Targets · doi:10.2174/138945011794751591 · Cited by 105
CUB-domain–containing protein 1 (CDCP1) activates Src to promote melanoma metastasis
Liu, H., Ong, S., Badu-Nkansah, K. A., Schindler, J. W., White, F. M., & Hynes, R. O. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017228108 · Cited by 104
Global Impact of Oncogenic Src on a Phosphotyrosine Proteome
Luo, W., Slebos, R. J. C., Hill, S., Li, M., Brábek, J., Amanchy, R., Chaerkady, R., Pandey, A., Ham, A. L., & Hanks, S. K. (2008) · Journal of Proteome Research · doi:10.1021/pr800187n · Cited by 101
Src as a potential therapeutic target in non-small-cell lung cancer
Giaccone, G., & Zucali, P. A. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn048 · Cited by 99
Smolinski, M. P., Bu, Y., Clements, J. L., Gelman, I. H., Hegab, T., Cutler, D. L., Fang, J. W. S., Fetterly, G. J., Kwan, R., Barnett, A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00164 · Cited by 98
Gelman, I. H. (2010) · Genes & Cancer · doi:10.1177/1947601910392984 · Cited by 97
Yeung, M. C., & Yam, V. W. (2013) · Chemical Science · doi:10.1039/c3sc50383f · Cited by 96
Carnevale, R. P., Proietti, C. J., Salatino, M., Urtreger, A. J., Peluffo, G., Edwards, D. P., Boonyaratanakornkit, V., Charreau, E. H., Joffé, E. B. D. K., Schillaci, R., et al. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0304 · Cited by 96
IQGAP1-Dependent Signaling Pathway Regulates Endothelial Cell Proliferation and Angiogenesis
Meyer, R., Sacks, D. B., & Rahimi, N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003848 · Cited by 95
Tian, J., Raffa, F. A., Dai, M., Moamer, A., Khadang, B., Hachim, I. Y., Bakdounes, K., Ali, S., Jean‐Claude, B. J., & Lebrun, J. J. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0287-3 · Cited by 97
Targeting Epidermal Growth Factor Receptor and Src Pathways in Head and Neck Cancer
Egloff, A. M., & Grandis, J. R. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.03.008 · Cited by 95
ErbB3-Dependent Motility and Intravasation in Breast Cancer Metastasis
Xue, C., Liang, F., Mahmood, R., Vuolo, M. A., Wyckoff, J. B., Qian, H., Tsai, K.-L., Kim, M., Locker, J. D., Zhang, Z., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-0550 · Cited by 94
Role of c-Src in Human MCF7 Breast Cancer Cell Tumorigenesis
González, L., Agulló-Ortuño, M. T., García-Martínez, J. M., Calcabrini, A., Gamallo, C., Palacios, J., Aranda, A., & Martı́n-Pérez, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601570200 · Cited by 95
Thomas, S., Overdevest, J. B., Nitz, M. D., Williams, P. D., Owens, C. R., Sanchez-Carbayo, M., Frierson, H. F., Schwartz, M. A., & Theodorescu, D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0730 · Cited by 92
El‐Karim, S. S. A., Anwar, M. M., Mohamed, N. A., Nasr, T., & Elseginy, S. A. (2015) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2015.08.006 · Cited by 92
Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches
Choi, H. J., Armaiz-Peña, G. N., Pradeep, S., Cho, M. S., Coleman, R. L., & Sood, A. K. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9538-9 · Cited by 92
Antitumor Effects and Biomarkers of Activity of AZD0530, a Src Inhibitor, in Pancreatic Cancer
Rajeshkumar, N. V., Tan, A. C., Oliveira, E. D., Womack, C., Wombwell, H., Morgan, S. R., Warren, M. V., Walker, J., Green, T. P., Jimeno, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3021 · Cited by 93
Pahujaa, M., Anikin, M., & Goldberg, G. S. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.09.010 · Cited by 88
Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis
Kim, M. P., Park, S. I., Kopetz, S., & Gallick, G. E. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0682-9 · Cited by 88
Self-citationDing, Q., Miyazaki, Y., Tsukasa, K., Matsubara, S., Yoshimitsu, M., & Takao, S. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-15 · Cited by 89
Locking the Active Conformation of c-Src Kinase through the Phosphorylation of the Activation Loop
Meng, Y., & Roux, B. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.10.001 · Cited by 89
Planas-Silva, M., Bruggeman, R. D., Grenko, R. T., & Smith, J. S. (2006) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2005.12.164 · Cited by 97
Dalgarno, D. C., Stehle, T., Narula, S. S., Schelling, P., van Schravendijk, M. R., Adams, S. E., Andrade, L. J., Keats, J. A., Ram, M. K., Jin, L., et al. (2005) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00316.x · Cited by 87
Fu, Y., Yang, G., Zhu, F., Peng, C., Li, W., Li, H., Kim, H.-G., Bode, A. M., Dong, Z., & Dong, Z. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.509 · Cited by 90
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
Lü, G., Zhang, Q. H., Huang, Y., Song, J., Tomaino, R., Ehrenberger, T., Lim, E., Liu, W., Bronson, R. T., Bowden, M., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.06.026 · Cited by 87
Woodcock, S. A., Rooney, C., Liontos, M., Connolly, Y., Zoumpourlis, V. C., Whetton, A. D., Gorgoulis, V. G., & Malliri, A. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.012 · Cited by 86
The Src Family of Protein Tyrosine Kinases: A New and Promising Target for Colorectal Cancer Therapy
Lieu, C. H., & Kopetz, S. (2010) · Clinical Colorectal Cancer · doi:10.3816/ccc.2010.n.012 · Cited by 88
Bacteria and genetically modified bacteria as cancer therapeutics: Current advances and challenges
Nallar, S. C., Xu, D.-Q., & Kalvakolanu, D. V. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.002 · Cited by 89
Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer
Yu, W., Chai, H., Li, Y., Zhao, H., Xie, X., Zheng, H., Wang, C., Wang, X., Yang, G., Cai, X., et al. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.07.019 · Cited by 86
Wang, N., Liang, H., Zhou, Y., Wang, C., Zhang, S., Pan, Y., Wang, Y., Yan, X., Zhang, J., Zhang, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105570 · Cited by 87
Tyrosine kinase receptor RON in human pancreatic cancer
Camp, E. R., Yang, A. D., Gray, M. J., Fan, F., Hamilton, S. R., Evans, D. B., Hooper, A. T., PEREIRA, D. S., Hicklin, D. J., & Ellis, L. M. (2007) · Cancer · doi:10.1002/cncr.22490 · Cited by 85
Src oncogene activates MMP‐2 expression via the ERK/Sp1 pathway
Kuo, L., Chang, H., Leu, T., Maa, M., & Hung, W. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20616 · Cited by 85
Src in endosomal membranes promotes exosome secretion and tumor progression
Hikita, T., Kuwahara, A., Watanabe, R., Miyata, M., & Oneyama, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-39882-z · Cited by 86
Ashour, A. A., Gürbüz, N., Alpay, S. N., Abdel‐Aziz, A. H., Mansour, A. M., Huo, L., & Özpolat, B. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12361 · Cited by 84
Chellappa, K., Jankova, L., Schnabl, J. M., Pan, S., Brélivet, Y., Fung, C. L.-S., Chan, C., Dent, O. F., Clarke, S. J., Robertson, G. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106799109 · Cited by 87
Dimri, M., Naramura, M., Duan, L., Chen, J., Ortega-Cava, C. F., Chen, G., Goswami, R., Fernandes, N. D., Gao, Q., Dimri, G. P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2580 · Cited by 87
Trevino, J. G., Summy, J. M., Gray, M. J., Nilsson, M. B., Lesslie, D. P., Baker, C. H., & Gallick, G. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3858 · Cited by 83
Self-citationJia, D., Jing, Y., Zhang, Z., Liu, L., Ding, J., Zhao, F., Ge, C., Wang, Q., Chen, T., Yao, M., et al. (2013) · Cell Research · doi:10.1038/cr.2013.158 · Cited by 81
Src family kinases and paclitaxel sensitivity
Le, X.-F., & Bast, Jr. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.4.16430 · Cited by 79
Structure–Activity Relationship of Benzofuran Derivatives with Potential Anticancer Activity
Farhat, J., Alzyoud, L., Alwahsh, M., & Al‐Omari, B. (2022) · Cancers · doi:10.3390/cancers14092196 · Cited by 79
Ammer, A. G., Kelley, L. C., Hayes, K. E., Evans, J. V., Lopez-Skinner, L. A., Martin, K. H., Frederick, B. A., Rothschild, B. L., Raben, D., Elvin, P., et al. (2009) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000009 · Cited by 79
Summy, J. M., Trevino, J. G., Lesslie, D. P., Baker, C. H., Shakespeare, W. C., Wang, Y., Sundaramoorthi, R., Metcalf, C. A., Keats, J. A., Sawyer, T. K., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0171 · Cited by 82
Self-citationLee, Y.-C., Huang, C.-F., Murshed, M., Chu, K., Araujo, J. C., Ye, X., deCrombrugghe, B., Yu-Lee, L.-Y., Gallick, G. E., & Lin, S.-H. (2010) · Oncogene · doi:10.1038/onc.2010.73 · Cited by 79
Self-citationHumbert, M., Castéran, N., Letard, S., Hanssens, K., Iovanna, J., Finetti, P., Bertucci, F., Bader, T., Mansfield, C. D., Moussy, A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009430 · Cited by 78
Burger, K. L., Learman, B. S., Boucherle, A. K., Sirintrapun, S. J., Isom, S. P., Díaz, B., Courtneidge, S. A., & Seals, D. F. (2013) · The Prostate · doi:10.1002/pros.22735 · Cited by 78
Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis
Rho, O., Kim, D. J., Kiguchi, K., & DiGiovanni, J. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20665 · Cited by 78
Hamamura, K., Tsuji, M., Hotta, H., Ohkawa, Y., Takahashi, M., Shibuya, H., Nakashima, H., Yamauchi, Y., Hashimoto, N., Hattori, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.164798 · Cited by 77
Ubiquitin ligases in cancer: Functions and clinical potentials
Duan, S., & Pagano, M. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.04.008 · Cited by 77
Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer
Bai, J., Zhou, Y., Chen, G., Zeng, J., Ding, J., Tan, Y., Zhou, J., & Li, G. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.09.003 · Cited by 76
Sánchez-Bailón, M. P., Calcabrini, A., Gómez-Domínguez, D., Morte, B., Martín-Forero, E., Goméz-López, G., Molinari, A., Wagner, K., & Martı́n-Pérez, J. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.02.011 · Cited by 76
Huang, Y., Yang, H., Huang, S.-W., Ou, G., Hsu, Y.-F., & Hsu, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158839 · Cited by 77
Ischenko, I., Čamaj, P., Seeliger, H., Kleespies, A., Guba, M. O., Toni, E. N. D., Schwarz, B., Graeb, C., Eichhorn, M., Jauch, K. ‐., et al. (2008) · Oncogene · doi:10.1038/onc.2008.326 · Cited by 75
Computational Study of the “DFG-Flip” Conformational Transition in c-Abl and c-Src Tyrosine Kinases
Meng, Y., Lin, Y.-L., & Roux, B. (2014) · Journal of Physical Chemistry B · doi:10.1021/jp511792a · Cited by 71
An Update on Src Family of Nonreceptor Tyrosine Kinases Biology
Espada, J., & Martín-Pérez, J. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.09.009 · Cited by 80
Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement
Serrels, A., Canel, M., Brunton, V. G., & Frame, M. C. (2011) · Cell Adhesion & Migration · doi:10.4161/cam.5.4.17290 · Cited by 74
7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as Dual Inhibitors of Src and Abl Kinases
Boschelli, D. H., Wang, Y. D., Johnson, S., Wu, B., Ye, F., Sosa, A. C. B., Golas, J. M., & Boschelli, F. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0499458 · Cited by 72
Targeting key steps in metastatic tumour progression
Eccles, S. A. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.001 · Cited by 73
Regional anaesthesia and cancer metastases: the implication of local anaesthetics
Votta-Velis, E. G., Piegeler, T., Minshall, R. D., Aguirre, J. A., Beck‐Schimmer, B., Schwartz, D. E., & Borgeat, A. (2013) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12210 · Cited by 73
Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer
Chen, Z., Cai, L., Zhu, J., Chen, M., Chen, J., Li, Z., Liu, X.-D., Wang, S., Bie, P., Jiang, P., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr088 · Cited by 74
Src controls tumorigenesis via JNK‐dependent regulation of the Hippo pathway in Drosophila
Enomoto, M., & Igaki, T. (2012) · EMBO Reports · doi:10.1038/embor.2012.185 · Cited by 73
Transition path theory analysis of c-Src kinase activation
Meng, Y., Shukla, D., Pande, V. S., & Roux, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602790113 · Cited by 73
Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
Liu, X., Liu, S., Lyu, H., Riker, A. I., Zhang, Y., & Liu, B. (2019) · Biological Procedures Online · doi:10.1186/s12575-019-0093-1 · Cited by 72
Leung, E. L., Wong, J. C., Johlfs, M. G., Tsang, B. K., & Fiscus, R. R. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0178 · Cited by 72
Weisberg, E., Liu, Q., Nelson, E. A., Kung, A. L., Christie, A. L., Bronson, R. T., Sattler, M., Sanda, T., Zhao, Z., Hur, W., et al. (2012) · Leukemia · doi:10.1038/leu.2012.96 · Cited by 73
Minard, M. E., Herynk, M. H., Collard, J. G., & Gallick, G. E. (2005) · Oncogene · doi:10.1038/sj.onc.1208503 · Cited by 72
Self-citationThe cell surface glycoprotein CDCP1 in cancer—Insights, opportunities, and challenges
Wortmann, A., He, Y., Deryugina, E. I., Quigley, J. P., & Hooper, J. D. (2009) · IUBMB Life · doi:10.1002/iub.198 · Cited by 72
Masraksa, W., Tanasawet, S., Hutamekalin, P., Wongtawatchai, T., & Sukketsiri, W. (2020) · Nutrition Research and Practice · doi:10.4162/nrp.2020.14.2.127 · Cited by 72
Je, D. W., Young Moon, O., Ji, Y. G., Cho, Y., & Lee, D. H. (2014) · Pancreas · doi:10.1097/mpa.0000000000000103 · Cited by 70
Parallels in invasion and angiogenesis provide pivotal points for therapeutic intervention
Eccles, S. A. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041820se · Cited by 71
YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib
Garmendia, I., Pajares, M. J., Hermida‐Prado, F., Ajona, D., Bértolo, C., Sainz, C., Lavín, A., Remírez, A., Valencia, K., Moreno, H., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1292oc · Cited by 73
Wang, X., Urvalek, A. M., Liu, J., & Zhao, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709300200 · Cited by 70
Oncogenic Src requires a wild-type counterpart to regulate invadopodia maturation
Kelley, L. C., Ammer, A. G., Hayes, K. E., Martin, K. H., Machida, K., Jia, L., Mayer, B. J., & Weed, S. A. (2010) · Journal of Cell Science · doi:10.1242/jcs.075200 · Cited by 70
Rao, V. K., Chhikara, B. S., Shirazi, A. N., Tiwari, R. K., Parang, K., & Kumar, A. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.05.010 · Cited by 70
Sharma, S., Singh, J., Ojha, R., Singh, H., Kaur, M., Bedi, P. M. S., & Nepali, K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.018 · Cited by 70
Little, A. C., Sham, D., Hristova, M., Danyal, K., Heppner, D. E., Bauer, R., Sipsey, L., Habibovic, A., & van der Vliet, A. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.61 · Cited by 70
Bosutinib Therapy Ameliorates Lung Inflammation and Fibrosis in Experimental Silicosis
Carneiro, P. J., Clevelario, A. L., Padilha, G. A., Silva, J. D., Kitoko, J. Z., Olsen, P. C., Capelozzi, V. L., Rocco, P. R. M., & Cruz, F. F. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00159 · Cited by 70
Lin, G., Aranda, V., Muthuswamy, S. K., & Tonks, N. K. (2011) · Genes & Development · doi:10.1101/gad.2018911 · Cited by 70
Sirvent, A., Bénistant, C., Pannequin, J., Veracini, L., Simon, V, Bourgaux, J.-F., Hollande, F., Cruzalegui, F., & Roche, S. (2010) · Oncogene · doi:10.1038/onc.2009.450 · Cited by 69
Chun, K., Lao, H., & Langenbach, R. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.117689 · Cited by 68
Evans, T. R. J., Cutsem, E. V., Moore, M. J., Bazin, I. S., Rosemurgy, A. S., Bodoky, G., Deplanque, G., Harrison, M., Melichar, B., Pezet, D., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw607 · Cited by 68
The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications
Szewczyk-Roszczenko, O. K., Roszczenko, P., Shmakova, A., Finiuk, N. S., Holota, S. M., Lesyk, R., Bielawska, A., Vassetzky, Y. S., & Bielawski, K. (2023) · Cells · doi:10.3390/cells12182312 · Cited by 72
Hingorani, P., Zhang, W., Gorlick, R. G., & Kolb, E. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1657 · Cited by 68
EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation
Huang, M., Anand, S., Murphy, E. A., Desgrosellier, J. S., Stupack, D. G., Shattil, S. J., Schlaepfer, D. D., & Cheresh, D. A. (2011) · Oncogene · doi:10.1038/onc.2011.450 · Cited by 67
Zhu, L., Qin, C., Li, T., Ma, X., Qiu, Y., Lin, Y., Ma, D., Qin, Z., Sun, C., Shen, X., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0464-9 · Cited by 69
Therapy escape mechanisms in the malignant prostate
Santer, F. R., Erb, H. H. H., & McNeill, R. V. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.005 · Cited by 67
Emerging Evidence for the Importance of Phosphorylation in the Regulation of NADPH Oxidases
Bokoch, G., Diebold, B. A., Kim, J.-S., & Gianni, D. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2590 · Cited by 68
Sawyer, T. K. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.1.1 · Cited by 65
Lu, J., Yang, W., Tsai, S.-M., Lin, Y., Chang, P.-H., Chen, J., Wang, H., Wu, J., Jin, S.-L. C., & Yuh, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076951 · Cited by 65
Wang, W., Liu, Y., & Liao, K. (2011) · BMC Cell Biology · doi:10.1186/1471-2121-12-49 · Cited by 65
Fallah‐Tafti, A., Foroumadi, A., Tiwari, R. K., Shirazi, A. N., Hangauer, D. G., Bu, Y., Akbarzadeh, T., Parang, K., & Shafiee, A. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.050 · Cited by 66
CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation
Subramaniam, V., Vincent, I. R., Gardner, H., Chan, E., Dhamko, H., & Jothy, S. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2007.04.008 · Cited by 65
Arcaroli, J. J., Touban, B. M., Tan, A. C., Varella-Garcia, M., Powell, R. W., Eckhardt, S. G., Elvin, P., Gao, D., & Messersmith, W. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0066 · Cited by 64
Hiscox, S., Jordan, N., Morgan, L. D., Green, T. P., & Nicholson, R. I. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9065-y · Cited by 64
Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma
Krejsgaard, T., Vetter‐Kauczok, C. S., Woetmann, A., Kneitz, H., Eriksen, K. W., Lovato, P., Zhang, Q., Wasik, M. A., Geisler, C., Ralfkiaer, E. M., et al. (2009) · Blood · doi:10.1182/blood-2008-09-181024 · Cited by 64
Src family kinases differentially influence glioma growth and motility
Lewis‐Tuffin, L. J., Feathers, R. W., Hari, P., Durand, N., Li, Z., Rodríguez, F. J., Bakken, K., Carlson, B. L., Schroeder, M. A., Sarkaria, J. N., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.06.001 · Cited by 63
Johnson, B., & Mahadevan, D. (2015) · Clinical Cancer Drugs · doi:10.2174/2212697x02666150602215823 · Cited by 67
Ahmed, H. E. A., El-Nassag, M. A. A., Hassan, A. A. E.-H., Okasha, R. M., Ihmaid, S. K., Fouda, A. M., Afifi, T. H., Aljuhani, A., & El-Agrody, A. M. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1476503 · Cited by 63
Egloff, A. M., & Grandis, J. R. (2009) · Journal of Oncology · doi:10.1155/2009/896407 · Cited by 64
Oneyama, C., Iino, T., Saito, K., Suzuki, K., Ogawa, A., & Okada, M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00941-09 · Cited by 70
Park, S. I., Shah, A. N., Zhang, J., & Gallick, G. E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.9.1207 · Cited by 64
Self-citation
Metadata
- Authors
- Summy, J. M., & Gallick, G. E.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Gallick, Gary E.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2003-12
- Volume
- 22
- Issue
- 4
- Pages
- 337-358
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W1589166971
- Cited by
- 827
- References
- 171
- Citations by year
- 2026: 15 · 2025: 15 · 2024: 17 · 2023: 17 · 2022: 26 · 2021: 27 · 2020: 26 · 2019: 35 · 2018: 32 · 2017: 28 · 2016: 32 · 2015: 37 · 2014: 64 · 2013: 55 · 2012: 49
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Cancer and Metastasis Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca065527-07)
- National Cancer Institute (U54CA090810, 2 R01 CA65527)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- Src family kinases, Src kinase, non-receptor tyrosine kinase, tumor progression, metastasis, constitutive kinase activation, v-Src, malignant transformation, cell migration and invasion, angiogenesis, apoptosis resistance, cancer therapeutics, colorectal cancer, breast cancer, melanoma, lung cancer
- MeSH terms
- Enzyme Activation, Humans, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Signal Transduction, Disease Progression, src-Family Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review